Veradermics Inc

Kursprognose für Veradermics Inc (MANE)

$138.780

+0.291 (+0.21%)Zum Schluss

Kursprognosen

1-Day Price Prediction
+1.73%
1-Week Prediction
-0.43%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.

Loading chart…

MANE-Prognose durch Analyse ähnlicher Charts

Alphio's MANE stock price prediction model matches the current Veradermics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $141.18 (+1.73%). The 1-week path is $138.18 (-0.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Soll ich Veradermics Inc-Aktien kaufen?

VeraDermics, Inc. (MANE) is a good buy right now due to its recent positive clinical trial results for its hair loss treatment, which saw 88.9% of participants reporting improvement, and an impressive year-to-date change of +716.35%. The stock is currently priced at $138.78, with analysts projecting a price target of $160 from Citi, suggesting a potential upside of 15.4%. However, the company has reported significant net losses, with a net income of -30,011,000 USD in Q1 2026, which remains a key risk.

MANE schloss am Friday bei $138.78, nachdem der Kurs +0.21% gestiegen ist

Veradermics Inc (MANE) last closed at $138.78, gaining +0.21%. These facts feed the 1-day and 1-week MANE price prediction above.

Prognose-Treiber

Die Prognose-Treiber von Veradermics Inc (MANE) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

Ähnliche Chartmuster

Aktien, deren jüngster Kursverlauf MANE am ähnlichsten ist, sortiert nach Ähnlichkeit.

Saisonalitätsanalyse für MANE

Loading chart…

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln